Search Results
HCV London - Dr Natasha Martin, Can antiviral therapy reduce the prevalence of hepatitis C?
HCV London - Dr Natasha Martin, Can antiviral therapy reduce the prevalence of hepatitis C? - part 2
The role of anti-viral therapy in reducing hepatitis C prevalence in people who inject drugs.
7- Dr. Natasha Martin
"Treatment as Prevention" for HCV prevention: could this work?
HCV London - Dr Ashley Brown, London hepatitis treatment landscape
HCV London - Dr Geraldine Strathdee, The Challenge for London
Return to Learn Q&A with Dr. Natasha Martin
HCV London - Dr Pete Bramley, Update on Scottish Action Plan
Primary HCV Prevention Among Injectors
Dr. Valdiserri speaks on TasP in HCV Infection
Daniel Fierer Fierer Part 1.wmv
